Search research articles
Contact Us
Filters
Showing results (131-140 of 268) with videos related to
Page
of 27
Sort By:
Journal of the National Cancer Institute
|
December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer
Alison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Oncology
|
January 9, 2025
Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies
Kanika Arora, Sarah P Suehnholz, Hongxin Zhang, et al.
JAMA Ophthalmology
|
September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy
Jasmine H Francis, James J Harding, Alison M Schram, et al.
The Oncologist
|
May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
Ian Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
JCO Precision Oncology
|
October 6, 2022
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With <i>ALK</i>/<i>ROS1</i>/<i>RET</i>-Rearranged Lung Cancers
Harper Hubbeling, Noura Choudhury, Jessica Flynn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2025
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
Changsong Qi, Lin Shen, Thierry Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
JCO Precision Oncology
|
September 14, 2020
CNS Metastases in Patients With <i>MET</i> Exon 14-Altered Lung Cancers and Outcomes With Crizotinib
Michael Offin, Jia Luo, Robin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 268) with videos related to
Sort By:
Page
of 27
Journal of the National Cancer Institute
|
December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer
Alison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Oncology
|
January 9, 2025
Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies
Kanika Arora, Sarah P Suehnholz, Hongxin Zhang, et al.
JAMA Ophthalmology
|
September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy
Jasmine H Francis, James J Harding, Alison M Schram, et al.
The Oncologist
|
May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
Ian Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
JCO Precision Oncology
|
October 6, 2022
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With <i>ALK</i>/<i>ROS1</i>/<i>RET</i>-Rearranged Lung Cancers
Harper Hubbeling, Noura Choudhury, Jessica Flynn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2025
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
Changsong Qi, Lin Shen, Thierry Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
JCO Precision Oncology
|
September 14, 2020
CNS Metastases in Patients With <i>MET</i> Exon 14-Altered Lung Cancers and Outcomes With Crizotinib
Michael Offin, Jia Luo, Robin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
Page
of 27